Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$450,000.00
Jul 1, 2015
Observational evaluation of immediate antiretroviral therapy on HIV incidence among HIV-positive men who have sex with men in Shanghai, China
$100,000.00
Jul 1, 2015
Elucidating the mechanisms and reverting the hematopoietic consequences of target gene deregulation by the oncogenic transcription factor E2A-PBX1
$433,320.00
Jul 1, 2015
Personalizing Radionuclide Therapy of Neuroendocrine Tumours
$100,000.00
Jul 1, 2015
The function and regulation of short-stature genes during limb development and chondrogenesis
$560,420.00
Jul 1, 2015
Modulators of epigenomic processes - a novel approach to cancer therapy
$1,695,053.00
Jul 1, 2015
Typical and atypical Alzheimer Disease: salivary tau biomarkers, therapy with neuromodulation, and disease subtypes.
$1,177,472.00
Jul 1, 2015
STandard versus Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI)
$100,000.00
Jul 1, 2015
Synapse formation, synaptic plasticity and neurodegeneration: The role of MEN1 gene
$100,000.00
Jul 1, 2015
Non-B DNA and retroviral integration site selection: implications for HIV gene expression, latency and cure-focused antiretrovirals.
$100,000.00
Jul 1, 2015
Investigations of low energy electron damage to DNA: application to Chemoradiation therapy.